1. Abstract 113: Thoracic Aortic Aneurysms Associated With Bicuspid Aortic Valve Have Altered MicroRNA Expression
- Author
-
Brett D. Hambly, Murat Kekic, Ratnasari Padang, Stefanie S. Portelli, Richmond W. Jeremy, Paul G. Bannon, Elizabeth N Robertson, and Donna Lai
- Subjects
Aortic valve ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Vascular disease ,Heart malformation ,Population ,medicine.disease ,Aortic aneurysm ,Bicuspid aortic valve ,medicine.anatomical_structure ,Valvular disease ,Internal medicine ,microRNA ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,education - Abstract
Bicuspid aortic valve (BAV) is the most common congenital heart malformation, affecting 1-2% of the population. BAV is caused by fusion of two of the three aortic valve leaflets in the heart during foetal development. Progressive dilatation of the thoracic aorta, resulting in aneurysm (TAA), develops in approximately 50% of individuals with BAV, and can be fatal. The cause of BAV-TAA is undetermined, however, current understanding suggests that it is a complex interplay between genetic susceptibility and the abnormal haemodynamic stress generated by the malformed valve. Changes in the expression of post-transcriptional genetic modifiers, such as microRNA (miRNA), can alter protein expression and disrupt normal tissue function, contributing to disease. miRNA are also viable therapeutic targets with demonstrated success in disease treatment. We hypothesised that there is altered expression of miRNA in BAV-TAA tissue that contributes to TAA development. Total RNA was isolated from aortic tissue of 11 patients with BAV-TAA (Age 54 ± 12 years; M:F 10:1), and 6 normal controls with no aortic disease (Age 35 ± 18 years; M:F 4:2). RNA was reverse transcribed with primers for 818 different miRNA and qPCR was performed using Taqman® OpenArray® Human miRNA Panels. A significant difference in miRNA expression was defined as a >±2 fold change (p
- Published
- 2018